Daniel Öhman is a Senior Section Director in Clinical Development at AstraZeneca, where they leverage their extensive background in Bioanalytical Chemistry and DMPK. Daniel has previously held various leadership roles, including Associate Director Clinical Development and Head at the Clinical Chemistry Unit at Sahlgrenska University Hospital, managing teams of scientists and overseeing complex global projects. With a Doctor of Philosophy in Clinical Pharmacology from Linköping University and a Master of Science in Analytical Chemistry, Daniel is recognized for their innovative problem-solving abilities and effective communication skills.
This person is not in the org chart
This person is not in any teams
This person is not in any offices